Terry-Ann Burrell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Terry-Ann Burrell
Earlier roles on record: CFO at Beam Therapeutics Inc. (BEAM) until August 9, 2024. Beam Therapeutics Inc. reported in an 8-K filed July 15, 2024 that Terry-Ann Burrell resigned as Chief Financial Officer and Treasurer, effective August 9, 2024. The proxy statement of Beam Therapeutics Inc. reports total compensation of $2,768,161 for Terry-Ann Burrell in fiscal 2024, including a base salary of $321,910. Disclosed compensation is on record for 6 fiscal years.
“On July 11, 2024, Terry-Ann Burrell notified Beam Therapeutics Inc. (the "Company") of her decision to resign as Chief Financial Officer and Treasurer of the Company, effective August 9, 2024, to pursue other opportunities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-08-09
-
Start not stated–2024-08-09
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Beam Therapeutics Inc. (BEAM) | — | $321,910 | $2,768,161 |
| 2023 | Beam Therapeutics Inc. (BEAM) | CFO | $505,000 | $2,557,844 |
| 2022 | Beam Therapeutics Inc. (BEAM) | CFO | $480,000 | $2,947,530 |
| 2021 | Beam Therapeutics Inc. (BEAM) | CFO | $441,000 | $3,938,904 |
| 2020 | Beam Therapeutics Inc. (BEAM) | CFO | $420,000 | $683,752 |
| 2019 | Beam Therapeutics Inc. (BEAM) | CFO | $147,180 | $4,302,723 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.